Epithelial cell transforming sequence 2 in human oral cancer

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Iyoda, Manabu ^a   Kasamatsu, Atsushi ^a,b   Ishigami, Takashi ^a   Nakashima, Dai ^a   Endo Sakamoto, Yosuke ^b   Ogawara, Katsunori ^b   Shiiba, Masashi ^b   Tanzawa, Hideki ^a,b   Uzawa, Katsuhiro ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR P16INK4A; CYCLIN DEPENDENT KINASE INHIBITOR P21CIP1; CYCLIN DEPENDENT KINASE INHIBITOR P27KIP1; CYCLIN E; DNA; EPITHELIAL CELL TRANSFORMING SEQUENCE 2; GUANINE NUCLEOTIDE EXCHANGE FACTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; CDK4 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; ECT2 PROTEIN, HUMAN; ONCOPROTEIN;

ADULT; AGE; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CHEEK MUCOSA; CONTROLLED STUDY; DNA CONTENT; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENDER; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GINGIVA; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; PRIMARY TUMOR; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT PALATE; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; CELL CYCLE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 78649760558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014082     Document Type: Article

References (47)

1. Sudbo J, Reith A (2005) The evolution of predictive oncology and molecularbased therapy for oral cancer prevention. Int J Cancer 115: 339-345.
2. Mashberg A, Boffetta P, Winkelman R, Garfinkel L (1993) Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 72: 1369-1375.
3. Macfarlane GJ, Zheng T, Marshall JR, Boffetta P, Niu S, et al. (1995) Alcohol, tobacco, diet and the risk of oral cancer: A pooled analysis of three case-control studies. European Journal of Cancer Part B: Oral Oncology 31: 181-187.
4. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
5. Marshall CJ (1991) Tumor suppressor genes. Cell 64: 313-326.
6. Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, et al. (2008) Hyaluronan-mediated motility: A target in oral squamous cell carcinoma. Int J Oncol 32: 1001-1009.
7. Tatsumoto T, Xie X, Blumenthal R, Okamoto I, Miki T (1999) Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol 147: 921-928.
8. Kim JE, Billadeau DD, Chen J (2005) The tandem BRCT domains of Ect2 are required for both negative and positive regulation of Ect2 in cytokinesis. J Biol Chem 280: 5733-5739.
9. Niiya F, Xie X, Lee KS, Inoue H, Miki T (2005) Inhibition of cyclindependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAP-dependent manner. J Biol Chem 280: 36502-36509.
10. Niiya F, Tatsumoto T, Lee KS, Miki T (2006) Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA. Oncogene 25: 827-837.
11. Hara T, Abe M, Inoue H, Yu LR, Veenstra TD, et al. (2006) Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase. Oncogene 25: 566-578.
12. Gomez del Pulgar T, Benitah SA, Valeron PF, Espina C, Lacal JC (2005) Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 27: 602-613.
13. Salhia B, Tran NL, Chan A, Wolf A, Nakada M, et al. (2008) The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol 173: 1828-1838.
14. Sano M, Genkai N, Yajima N, Tsuchiya N, Homma J, et al. (2006) Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep 16: 1093-1098.
15. Justilien V, Fields AP (2009) Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene 28: 3597-3607.
16. Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, et al. (2004) Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation. J Biol Chem 279: 7169-7179.
17. Zhang ML, Lu S, Zhou L, Zheng SS (2008) Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer. Hepatobiliary Pancreat Dis Int 7: 533-538.
18. Yang YL, Chu JY, Luo ML, Wu YP, Zhang Y, et al. (2008) Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes Chromosomes Cancer Feb: 47(2): 127-36.
19. Hussenet T, Dali S, Exinger J, Monga B, Jost B, et al. (2010) SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One Jan 29: 5(1): e8960.
20. Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420: 629-635.
21. Ridley AJ (2001) Rho family proteins: coordinating cell responses. Trends Cell Biol 11: 471-477.
22. Boettner B, Van Aelst L (2002) The role of Rho GTPases in disease development. Gene 286: 155-174.
23. Pan Y, Bi F, Liu N, Xue Y, Yao X, et al. (2004) Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 315: 686-691.
24. Coleman ML, Marshall CJ, Olson MF (2004) RAS and RHO GTPases in G1- phase cell-cycle regulation. Nat Rev Mol Cell Biol 5: 355-366.
25. Villalonga P, Ridley AJ (2006) Rho GTPases and cell cycle control. Growth Factors 24: 159-164.
26. Yamamoto M, Marui N, Sakai T, Morii N, Kozaki S, et al. (1993) ADPribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene 8: 1449-1455.
27. Olson MF, Ashworth A, Hall A (1995) An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269: 1270-1272.
28. Olson MF, Paterson HF, Marshall CJ (1998) Signals from ras and rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394: 295-299.
29. Coleman ML, Densham RM, Croft DR, Olson MF (2006) Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton. Oncogene 25: 2708-2716.
30. Croft DR, Olson MF (2006) The rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms. Mol Cell Biol 26: 4612-4627.
31. Coleman ML, Marshall CJ, Olson MF (2003) Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome mediated degradation. EMBO J 22: 2036-46.
32. McFarlane C, Kelvin AA, de la Vega M, Govender U, Scott CJ, et al. (2010) The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. Cancer Res 70: 3329-3339.
33. Quelle DE, Ashmun RA, Shurtleff SA, Kato J, Bar-Sagi D, et al. (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7: 1559-1571.
34. Musgrove EA, Lee CSL, Buckley MF, Sutherland RL (1994) Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci U S A 91: 8022-8026.
35. Tam SW, Theodoras AM, Shay JW, Draetta GF, Pagano M (1994) Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9: 2663-2674.
36. Yong Liu, Wen Li, Caisheng Ye, Ying Lin, Tuck-Yun Cheang, et al. (2010) Gambogic Acid Induces G0/G1 Cell Cycle Arrest and Cell Migration Inhibition Via Suppressing PDGF Receptor bTytosine Phosphorylation and Rac1 Activity in Rat Aortic Smooth Muscle Cells. J Atheroscler Thromb Jun 11.
37. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
38. Kasamatsu A, Uzawa K, Nakashima D, Koike H, Shiiba M, et al. (2005) Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int J Mol Med 16: 269-273.
39. Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, et al. (2004) Sarcoendoplasmic reticulum Ca2+ ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer 110: 225-231.
40. Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, et al. (2005) Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 92: 1915-1921.
41. Saito K, Uzawa K, Endo Y, Kato Y, Nakashima D, et al. (2006) Plasma membrane Ca2+ ATPase isoform 1 down-regulated in human oral cancer. Oncol Rep 15: 49-55.
42. Onda T, Uzawa K, Endo Y, Bukawa H, Yokoe H, et al. (2006) Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma. Br J Cancer 94: 698-709.
43. Kouzu Y, Uzawa K, Koike H, Saito K, Nakashima D, et al. (2006) Overexpression of stathmin in oral squamous-cell carcinoma: Correlation with tumour progression and poor prognosis. Br J Cancer 94: 717-723.
44. Kato Y, Uzawa K, Yamamoto N, Kouzu Y, Koike H, et al. (2007) Overexpression of Septin1: Possible contribution to the development of oral cancer. Int J Oncol 31: 1021-1028.
45. Nomura H, Uzawa K, Yamano Y, Fushimi K, Ishigami T, et al. (2009) Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: Correlation with lymphovascular invasion and lymph-node metastasis. Hum Pathol 40: 83-91.
46. Sakuma T, Uzawa K, Onda T, Shiiba M, Yokoe H, et al. (2006) Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. Int J Oncol 29: 117-124.
47. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H, et al. (2003) Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82: 607-611.